Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00132223|
Recruitment Status : Unknown
Verified April 2006 by University Hospital Muenster.
Recruitment status was: Recruiting
First Posted : August 19, 2005
Last Update Posted : April 12, 2006
Angiographies of the supra-aortic vessels by magnetic imaging have become common recently. So it was the purpose of this study to evaluate the imaging potential of different contrast agents.
Three contrast agents for magnetic resonance imaging are compared in angiographies of the supra-aortic arteries in a intraindividual study of 10 patients.
All applications of these contrast agents are performed with a flow of 2 ml/s. One contrast medium is applicated a second time with a reduced flow of 1 ml/s.
The angiographies of the supra-aortic vessels are evaluated by two experienced readers in a consensus reading. The signal/noise- and contrast/noise-ratio of anatomic vessel segments of the carotic and vertebral arteries are measured and compared to each other.
|Condition or disease||Intervention/treatment||Phase|
|Headache Epilepsy Dizziness||Drug: Contrast agent||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging|
|Study Start Date :||April 2005|
|Study Completion Date :||December 2005|
- intensity of vessels, muscle, air
- signal/noise ratio
- contrast/nose ratio
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00132223
|Contact: Boris Buerke, MDemail@example.com|
|Contact: Bernd Tombach, MDfirstname.lastname@example.org|
|University of Muenster, Dept. of Clinical Radiology||Recruiting|
|Muenster, Germany, 48129|
|Contact: Boris Buerke, MD 00492518345123 email@example.com|
|Contact: Bernd Tombach 00492518345123 firstname.lastname@example.org|
|Principal Investigator: Bernd Tombach, MD|
|Sub-Investigator: Boris Buerke, MD|
|Study Chair:||Bernd Tombach, MD||University of Muenster, Dept. of Clinical Radiology|